Blog
RSS FeedPosted by Michael Wonder on 31 Jul 2017
Bupa’s call to scrap approval process for health cover premiums
29 July 2017 - Health insurance giant Bupa has called on the government to remove the need for ministerial approval ...
Posted by Michael Wonder on 31 Jul 2017
Private health insurance tipped to be ‘a luxury’ for one in five
31 July 2017 - Private health insurance is on track to become unaffordable for one in five policyholders, the peak ...
Posted by Michael Wonder on 31 Jul 2017
New Zealand Pharmaceutical Schedule - 1 August 2017
1 August 2017 - The August 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Jul 2017
NICE bars obesity pill from routine NHS use
31 July 2017 - Cost regulators for NHS treatments in England and Wales are standing by their position that Orexigen’s ...
Posted by Michael Wonder on 30 Jul 2017
Miracle Opdivo cancer drug that saved Jarryd Roughead’s life discounted for patients
30 July 2017 - The miracle drug that saved Hawthorn star Jarryd Roughead’s life will be made available at a ...
Posted by Michael Wonder on 29 Jul 2017
‘It’s very frustrating’: ovarian cancer patient waiting on potential approval of new treatment
27 July 2017 - Seventy-five women are diagnosed with ovarian cancer in Saskatchewan each year, and fifty-five lose their lives. ...
Posted by Michael Wonder on 28 Jul 2017
New drug to help over 200,000 Australians
28 July 2017 - The Australian Government has taken another significant step to eliminate hepatitis C from Australia by subsidising a ...
Posted by Michael Wonder on 27 Jul 2017
£3 a day drug for irritable bowel syndrome gets NICE approval
27 July 2017 - The drug, Truberzi has been recommended for routine funding on the NHS to treat patients with irritable ...
Posted by Michael Wonder on 27 Jul 2017
'We have been waiting for this moment for so long': hepatitis C patients have access to cure with Epclusa PBS listing
28 July 2017 - More than 200,000 Australians with hepatitis C will soon be able to afford a new, highly ...
Posted by Michael Wonder on 27 Jul 2017
Statins should be offered to everyone who has chronic kidney disease, says NICE
27 July 2017 - Healthcare professionals should offer statins to millions of people with chronic kidney disease. ...
Posted by Michael Wonder on 26 Jul 2017
Roche hails 4 year NICE access deal for Gazyvaro
26 July 2017 - NICE has agreed a deal with Roche on its new follicular lymphoma treatment Gazyvaro, giving the ...
Posted by Michael Wonder on 26 Jul 2017
NICE approval for nivolumab provides new treatment for advanced blood cancer
26 July 2017 - People with an advanced type of blood cancer will benefit from nivolumab on the NHS following approval ...
Posted by Michael Wonder on 26 Jul 2017
Post-market review of pulmonary arterial hypertension medicines – public consultation process
26 July 2017 - The public consultation process on the post-market review of the pulmonary arterial hypertension medicines has now ...
Posted by Michael Wonder on 25 Jul 2017
Vismodegib for treatment of patients with basal cell carcinoma
20 July 2017 - The Department of Health has asked the NICE to produce guidance on the use vismodegib in the ...
Posted by Michael Wonder on 25 Jul 2017
The Tasmanian hepatitis C buyers’ club
25 July 2017 - In 2014, when Greg Jefferys’s urine started smelling like dead meat, he knew there was something ...